Jetzt noch länger handeln: 7:30 - 23:00
Mit uns direkt oder auf gettex.
Über Deinen Broker oder Deine Bank.

Bellevue F (Lux) Bellevue Obesity Solutions B EUR

WKNA0X8YU
AssetklasseAktien
616,506-1,64
-0,27%
30.12.2025 12:47
616,506-1,64
-0,27%
30.12.2025 12:47
Verkaufen
616,417VerkaufenStück: 60
Kaufen
629,608KaufenStück: 60
Eröffnung
612,459
Hoch
616,506
Tief
612,459
Fund seeks to achieve long-term capital growth by investing at least two-thirds of the net assets in a portfolio of carefully chosen shares and preference shares of companies whose business is directed towards the prevention and treatment of overweight or obesity and their secondary conditions or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. The Fund invests in biotech equities worldwide but mainly US.
Emittent
Waystone Management Company (Lux) SA
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
35,665
Gesamtkostenquote (TER)
2,17 %
Tracking Difference
1,3727
Replikation
-
Fondswährung
EUR
Domizil
LU
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
620,89
NAV Datum
23.12.2025